| Select | PubMed ID | Description |
| 14720271 | Clin Exp Allergy. 2004 Jan;34(1):115-22.
Vaccines for birch pollen allergy based on genetically engineered hypoallergenic
derivatives of the major birch pollen allergen, Bet v 1.
Mahler V(1), Vrtala S, Kuss O, Diepgen TL, Suck R, Cromwell O, Fiebig H, Hartl A,
Thalhamer J, Schuler G, Kraft D, Valenta R.
|
| 22092996 | Clin Exp Allergy. 2011 Dec;41(12):1804-14. doi: 10.1111/j.1365-2222.2011.03866.x.
Epub 2011 Sep 23.
Bet v 1-like pollen allergens of multiple Fagales species can sensitize atopic
individuals.
Hauser M(1), Asam C, Himly M, Palazzo P, Voltolini S, Montanari C, Briza P,
Bernardi ML, Mari A, Ferreira F, Wallner M.
|
| 24224690 | Allergy. 2014 Feb;69(2):208-15. doi: 10.1111/all.12306. Epub 2013 Nov 14.
Differences in the intrinsic immunogenicity and allergenicity of Bet v 1 and
related food allergens revealed by site-directed mutagenesis.
Roulias A(1), Pichler U, Hauser M, Himly M, Hofer H, Lackner P, Ebner C, Briza P,
Bohle B, Egger M, Wallner M, Ferreira F.
|
| 31771108 | Foods. 2019 Nov 22;8(12). pii: E609. doi: 10.3390/foods8120609.
Purification and Characterization of Pathogenesis Related Class 10 Panallergens.
McBride JK(1), Cheng H(1), Maleki SJ(1), Hurlburt BK(1).
|
| 33013894 | Front Immunol. 2020 Sep 3;11:2118. doi: 10.3389/fimmu.2020.02118. eCollection
In vivo Induction of Functional Inhibitory IgG Antibodies by a Hypoallergenic Bet
v 1 Variant.
Aglas L(1), Bethanis A(1), Chrusciel P(2), Stolz F(3), Gruen M(1), Jaakkola
UM(2), Jongejan L(4), Yatkin E(2), Van Ree R(4).
|
| 33603065 | Sci Rep. 2021 Feb 18;11(1):4173. doi: 10.1038/s41598-021-83705-z.
Inverse relation between structural flexibility and IgE reactivity of Cor a 1
hazelnut allergens.
Führer S(1), Kamenik AS(2), Zeindl R(1), Nothegger B(3), Hofer F(2), Reider N(3),
Liedl KR(2), Tollinger M(4).
|
| 33724487 | Allergy. 2021 Aug;76(8):2555-2564. doi: 10.1111/all.14817. Epub 2021 May 6.
IgE-cross-blocking antibodies to Fagales following sublingual immunotherapy with
recombinant Bet v 1.
Grilo JR(1), Kitzmüller C(1), Aglas L(2), Sánchez Acosta G(1), Vollmann U(1),
Ebner C(3), Horak F(4), Kinaciyan T(5), Radauer C(1), Ferreira F(2), Jahn-Schmid
B(1), Bohle B(1).
|
| 34837242 | Allergy. 2021 Nov 27. doi: 10.1111/all.15191. [Epub ahead of print]
Isolation of nanobodies with potential to reduce patients' IgE binding to Bet v
Zettl I(1), Ivanova T(2), Strobl MR(3), Weichwald C(1), Goryainova O(2), Khan
E(2), Rutovskaya MV(2)(4), Focke-Tejkl M(1), Drescher A(5), Bohle B(3), Flicker
S(1), Tillib SV(2).
|
